| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | - | 10.578 | 15.766 | 15.187 | 11.901 | 14.692 | 21.742 |
| Total Income - EUR | 0 | 0 | 0 | - | 10.578 | 28.164 | 15.187 | 22.040 | 14.800 | 27.850 |
| Total Expenses - EUR | 0 | 0 | 0 | - | 14.042 | 20.371 | 19.265 | 17.601 | 21.364 | 27.314 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | - | -3.465 | 7.793 | -4.078 | 4.438 | -6.564 | 536 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | - | -3.571 | 7.522 | -4.230 | 4.222 | -6.709 | 258 |
| Employees | 0 | 0 | 0 | - | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vamedi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | - | 0 | 0 | 32 | 12 | 0 | 376 |
| Current Assets | 9 | 8 | 8 | - | 5.380 | 5.195 | 7.257 | 8.063 | 13.055 | 8.463 |
| Inventories | 0 | 0 | 0 | - | 5.092 | 4.510 | 6.212 | 7.012 | 10.459 | 7.677 |
| Receivables | 9 | 8 | 8 | - | 124 | 328 | 669 | 917 | 516 | 181 |
| Cash | 0 | 0 | 0 | - | 164 | 356 | 376 | 134 | 2.081 | 605 |
| Shareholders Funds | -4.160 | -4.118 | 8 | - | -7.525 | 140 | -4.093 | 117 | -6.593 | -6.321 |
| Social Capital | 45 | 45 | 44 | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.169 | 4.126 | 0 | - | 12.905 | 5.054 | 11.383 | 7.958 | 19.648 | 15.160 |
| Income in Advance | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Vamedi Srl